)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Marksans Pharma (MARKSANS) investor relations material
Marksans Pharma Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary14 Nov, 2025
Executive summary
Q2 FY 2026 saw a 16% sequential revenue increase, driven by robust demand and operational execution in the U.S. and stable performance in the U.K. despite pricing pressures.
EBITDA and PAT grew 44% and 70% quarter-on-quarter, reflecting operating leverage and improved execution.
Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, were approved with unmodified auditor opinions.
The group operates solely in the Pharmaceuticals segment.
Financial highlights
Q2 FY 2026 operating revenue was ₹720.4 crore, up 16.2% QoQ and 12.2% YoY; H1 FY 2026 revenue reached ₹1,340.4 crore, up 8.8% YoY.
Q2 FY 2026 EBITDA was ₹144.5 crore (20.1% margin), up 44.3% QoQ and 6.5% YoY; PAT at ₹99.1 crore, up 70.3% QoQ and 1.4% YoY.
H1 FY 2026 gross profit was ₹770 crore (gross margin 57.4%), EBITDA ₹244.6 crore (margin 18.2%), PAT ₹157.3 crore.
Cash generated from operations in H1 was ₹75.2 crore; CapEx at ₹73.2 crore; cash balance at ₹666.5 crore as of September 30, 2025.
Standalone and consolidated revenues and profits grew year-over-year, with consolidated H1 FY26 revenue at ₹13,403.98 million and net profit at ₹1,573.41 million.
Outlook and guidance
Confident in sustaining growth momentum for the rest of FY 2026, supported by a robust product pipeline and operational discipline.
Targeting ₹3,000 crore revenue by next year and ₹5,000 crore over five to seven years; U.K. revenue expected to double in five to seven years.
Strategic focus on expanding OTC business, scaling manufacturing, and disciplined capital allocation.
Marksans Employees Stock Option Scheme 2024 was approved, granting 400,000 equity stock options.
When will next capacity expansion CapEx begin?
Expected Europe revenue contribution by FY28?
U.S. tariff clarity: any strategic shifts?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Marksans Pharma earnings date
Q3 25/2611 Feb, 2026
Next Marksans Pharma earnings date
Q3 25/2611 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Marksans Pharma Limited is a pharmaceutical company engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. The company produces a wide range of dosage forms including tablets, capsules, liquids, and ointments across therapeutic areas such as pain management, gastrointestinal, cardiovascular, and anti-infective segments. It serves regulated and semi-regulated markets including the United States, Europe, Australia, and emerging regions. Marksans Pharma Limited operates manufacturing facilities compliant with global regulatory standards and offers contract manufacturing services. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage